IRAK-M regulation and function in host defense and immune homeostasis

Infectious Disease Reports

Volumn 2, Issue 1, 2010, Pages 22-29

  Hubbard, Leah L N ^a   Moore, Bethany B ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Immune regulation; Inflammation; Sepsis

Indexed keywords

B7 ANTIGEN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 3; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR AP 1;

ARTICLE; ASTHMA; CELL SURFACE; CELLULAR DISTRIBUTION; COMPLEX FORMATION; ENDOTOXIN DETECTION; ENTERITIS; ENZYME ACTIVITY; GRAFT INFECTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOST RESISTANCE; HUMAN; IMMUNE DEFICIENCY; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INFLAMMATION; INFLUENZA; MACROPHAGE; NONHUMAN; PERIODONTAL DISEASE; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SEPSIS; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

EID: 79952505326     PISSN: None     EISSN: 20367449     Source Type: Journal    
DOI: 10.4081/idr.2010.e9     Document Type: Article

References (74)

1. Wang J, Hu Y, Deng WW, Sun B. Negative regulation of Toll-like receptor signaling pathway. Microbes Infect 2009;11:321-7.
2. Fukao T, Koyasu S. PI3K and negative regulation of TLR signaling. Trends Immunol 2003;24:358-63.
3. Wesche H, Gao X, Li X et al. IRAK-M is a novel member of the Pelle/interleukin-1 receptor-associated kinase (IRAK) family. J Biol Chem 1999;274:19403-10.
4. Hardy M P, O'Neill LA. The murine IRAK2 gene encodes four alternatively spliced isoforms, two of which are inhibitory. J Biol Chem 2004;279:27699-708.
5. Rosati O, Martin MU. Identification and characterization of murine IRAK-M. Biochem Biophys Res Commun 2002; 293:1472-7.
6. Janssens S, Beyaert R. Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members. Mol Cell 2003;11:293-302.
7. Kobayashi K, Hernandez LD, Galan JE et al. IRAK-M is a negative regulator of Tolllike receptor signaling. Cell 2002;110:191-202.
8. Balaci L, Spada MC, Olla N et al. IRAK-M is involved in the pathogenesis of early-onset persistent asthma. Am J Hum Genet 2007; 80:1103-14.
9. Lagler H, Sharif O, Haslinger I et al. TREM-1 activation alters the dynamics of pulmonary IRAK-M expression in vivo and improves host defense during pneumococcal pneumonia. J Immunol 2009;183:2027-36.
10. Seki M, Kohno S, Newstead MW et al. Critical role of IL-1 receptor-associated kinase-M in regulating chemokine-dependent deleterious inflammation in murine influenza pneumonia. J Immunol 2010;184:1410-8.
11. Hubbard LL, Ballinger MN, Thomas PE et al. A role for IL-1 Receptor-associated kinase-M in Prostaglandin E(2)-induced immunosuppression post-bone marrow transplantation. J Immunol 2010;184:6299-308.
12. Meyer-Bahlburg A, Khim S, Rawlings DJ. B cell intrinsic TLR signals amplify but are not required for humoral immunity. J Exp Med 2007;204:3095-101.
13. Harada K, Nakanuma Y. Biliary innate immunity and cholangiopathy. Hepatol Res 2007;37:S430-7.
14. Oshima N, Ishihara S, Rumi MA et al. A20 is an early responding negative regulator of Toll-like receptor 5 signalling in intestinal epithelial cells during inflammation. Clin Exp Immunol 2010;159:185-98.
15. Neumann M, Naumann M. Beyond IkappaBs: alternative regulation of NF-kappaB activity. FASEB J 2007;21:2642-54.
16. Xiao G, Rabson AB, Young W et al. Alternative pathways of NF-kappaB activation: a double-edged sword in health and disease. Cytokine Growth Factor Rev 2006; 17:281-93.
17. del Fresno C, Garcia-Rio F, Gomez-Pina V et al. Potent phagocytic activity with impaired antigen presentation identifying lipopolysaccharide-tolerant human monocytes: demonstration in isolated monocytes from cystic fibrosis patients. J Immunol 2009;182:6494-507.
18. Su J, Zhang T, Tyson J, Li L. The Interleukin-1 Receptor-Associated Kinase M Selectively Inhibits the Alternative, Instead of the Classical NFkappaB Pathway. J Innate Immun 2009;1:164-74.
19. Yoshida H, Jono H, Kai H, Li JD. The tumor suppressor cylindromatosis (CYLD) acts as a negative regulator for toll-like receptor 2 signaling via negative cross-talk with TRAF6 AND TRAF7. J Biol Chem 2005;280: 41111-21.
20. Su J, Xie Q, Wilson I, Li L. Differential regulation and role of interleukin-1 receptor associated kinase-M in innate immunity signaling. Cell Signal 2007;19:1596-601.
21. Orabona C, Grohmann U, Belladonna ML et al. CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86. Nat Immunol 2004;5:1134-42.
22. Nolan A, Kobayashi H, Naveed B et al. Differential role for CD80 and CD86 in the regulation of the innate immune response in murine polymicrobial sepsis. PLoS One 2009;4:e6600.
23. Mages J, Dietrich H, Lang R. A genome-wide analysis of LPS tolerance in macrophages. Immunobiology 2007;212: 723-37.
24. Nakayama K, Okugawa S, Yanagimoto S et al. Involvement of IRAK-M in peptidoglycan-induced tolerance in macrophages. J Biol Chem 2004;279:6629-34.
25. Kim HG, Kim NR, Gim MG et al. Lipoteichoic acid isolated from Lactobacillus plantarum inhibits lipopoly -saccharide-induced TNF-alpha production in THP-1 cells and endotoxin shock in mice. J Immunol 2008;180:2553-61.
26. Hassan F, Islam S, Tumurkhuu G et al. Involvement of interleukin-1 receptor-associated kinase (IRAK)-M in toll-like receptor (TLR) 7-mediated tolerance in RAW 264.7 macrophage-like cells. Cell Immunol 2009;256:99-103.
27. Hayashi T, Gray CS, Chan M et al. Prevention of autoimmune disease by induction of tolerance to Toll-like receptor 7. Proc Natl Acad Sci USA 2009;106:2764-9.
28. Kim YI, Park JE, Martinez-Hernandez A, Yi AK. CpG DNA prevents liver injury and shock-mediated death by modulating expression of interleukin-1 receptor-associated kinases. J Biol Chem 2008;283: 15258-70.
29. Tazi KA, Quioc JJ, Saada V et al. Upregulation of TNF-alpha production signaling pathways in monocytes from patients with advanced cirrhosis: possible role of Akt and IRAK-M. J Hepatol 2006; 45:280-9.
30. Escoll P, del Fresno C, Garcia L et al. Rapid up-regulation of IRAK-M expression following a second endotoxin challenge in human monocytes and in monocytes isolated from septic patients. Biochem Biophys Res Commun 2003;311:465-72.
31. Zacharioudaki V, Androulidaki A, Arranz A et al. Adiponectin promotes endotoxin tolerance in macrophages by inducing IRAK-M expression. J Immunol 2009;182:6444-51.
32. Stofkova A. Leptin and adiponectin: from energy and metabolic dysbalance to inflammation and autoimmunity. Endocr Regul 2009;43:157-68.
33. Taylor AW. The immunomodulating neuropeptide alpha-melanocyte-stimulating hormone (alpha-MSH) suppresses LPS-stimulated TLR4 with IRAK-M in macrophages. J Neuroimmunol 2005;162: 43-50.
34. Shen W, Stone K, Jales A et al. Inhibition of TLR activation and up-regulation of IL-1R-associated kinase-M expression by exogenous gangliosides. J Immunol 2008;180: 4425-32.
35. Yatabe T, Mochizuki S, Takizawa M et al. Hyaluronan inhibits expression of ADAMTS4 (aggrecanase-1) in human osteoarthritic chondrocytes. Ann Rheum Dis 2009;68:1051-8.
36. del Fresno C, Otero K, Gomez-Garcia L et al. Tumor cells deactivate human monocytes by up-regulating IL-1 receptor associated kinase-M expression via CD44 and TLR4. J Immunol 2005;174:3032-40.
37. Greenhough A, Smartt HJ, Moore AE et al. The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis 2009;30:377-86.
38. Berclaz PY, Carey B, Fillipi MD et al. GM-CSF Regulates a PU.1-Dependent Transcriptional Program Determining the Pulmonary Response to LPS. Am J Respir Cell Mol Biol 2007;36:114-21.
39. Gonzalez-Leon MC, Soares-Schanoski A, del Fresno C et al. Nitric oxide induces SOCS-1 expression in human monocytes in a TNF-alpha-dependent manner. J Endotoxin Res 2006;12:296-306.
40. del Fresno C, Gomez-Garcia L, Caveda L et al. Nitric oxide activates the expression of IRAK-M via the release of TNF-alpha in human monocytes. Nitric Oxide 2004; 10:213-20.
41. van't Veer C, van den Pangaart PS, van Zoelen MA et al. Induction of IRAK-M is associated with lipopolysaccharide tolerance in a human endotoxemia model. J Immunol 2007;179:7110-20.
42. Pan H, Ding E, Hu M. SMAD4 is required for development of maximal endotoxin tolerance. J Immunol 2010;184:5502-9.
43. Geijtenbeek TB, Van Vliet SJ, Koppel EA et al. Mycobacteria target DC-SIGN to suppress dendritic cell function. J Exp Med 2003;197:7-17.
44. Maeda N, Nigou J, Herrmann JL et al. The cell surface receptor DC-SIGN discriminates between Mycobacterium species through selective recognition of the man-nose caps on lipoarabinomannan. J Biol Chem 2003;278:5513-6.
45. Nigou J, Zelle-Rieser C, Gilleron M et al. Mannosylated lipoarabinomannans inhibit IL-12 production by human dendritic cells: evidence for a negative signal delivered through the mannose receptor. J Immunol 2001;166:7477-85.
46. Pathak SK, Basu S, Bhattacharyya A et al. Mycobacterium tuberculosis lipoarabinomannan-mediated IRAK-M induction negatively regulates Toll-like receptor-dependent interleukin-12 p40 production in macrophages. J Biol Chem 2005;280: 42794-800.
47. Scotton CJ, Martinez FO, Smelt MJ et al. Transcriptional profiling reveals complex regulation of the monocyte IL-1 beta system by IL-13. J Immunol 2005;174:834-45.
48. Biswas SK, Lopez-Collazo E. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol 2009;30:475-87.
49. Takebayashi K, Hokari R, Kurihara C et al. Oral tolerance induced by enterobacteria altered the process of lymphocyte recruitment to intestinal microvessels: roles of endothelial cell adhesion molecules, TGF-beta and negative regulators of TLR signaling. Microcirculation 2009;16:251-64.
50. Weersma RK, Oostenbrug LE, Nolte IM et al. Association of interleukin-1 receptor-associated kinase M (IRAK-M) and inflammatory bowel diseases. Scand J Gastroenterol 2007;42:827-33.
51. Shen H, Goldstein DR. IL-6 and TNF-alpha synergistically inhibit allograft acceptance. J Am Soc Nephrol 2009;20:1032-40.
52. Sun K, Metzger DW. Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection. Nat Med 2008;14:558-64.
53. Domon H, Honda T, Oda T, et al. Early and preferential induction of IL-1 receptor-associated kinase-M in THP-1 cells by LPS derived from Porphyromonas gingivalis. J Leukoc Biol 2008;83:672-9.
54. Wiersinga WJ, van't Veer C, van den Pangaart PS et al. Immunosuppression associated with interleukin-1R-associated-kinase-M upregulation predicts mortality in Gram-negative sepsis (melioidosis). Crit Care Med 2009;37:569-76.
55. Deng JC, Cheng G, Newstead MW et al. Sepsis-induced suppression of lung innate immunity is mediated by IRAK-M. J Clin Invest 2006;116:2532-42.
56. del Fresno C, Otero K, Gomez-Garcia L et al. Tumor cells deactivate human monocytes by up-regulating IL-1 receptor associated kinase-M expression via CD44 and TLR4. J Immunol 2005;174:3032-40.
57. Xie Q, Gan L, Wang J et al. Loss of the innate immunity negative regulator IRAK-M leads to enhanced host immune defense against tumor growth. Mol Immunol 2007;44:3453-61.
58. Auletta JJ, Lazarus HM. Immune restoration following hematopoietic stem cell transplantation: an evolving target. Bone Marrow Transplant 2005;35:835-57.
59. Kotloff R, Ahya V, Crawford SW. Pulmonary complications of solid organ and hematopoietic stem cell transplantation. Am J Respir Crit Care Med 2004;170:22-48.
60. Ballinger MN, Aronoff DM, McMillan TR, et al. Critical Role of Prostaglandin E2 Overproduction in Impaired Pulmonary Host Response Following Bone Marrow Transplantation. J Immunol 2006;177: 5499-508.
61. Ojielo C, Cooke KR, Mancuso P et al. Defective phagocytosis and clearance of Pseudomonas aeruginosa in the Lung Following Bone Marrow Transplantation. J Immunol 2003;171:4416-24.
62. Chuang TH, Ulevitch RJ. Triad3A, an E3 ubiquitin-protein ligase regulating Tolllike receptors. Nat Immunol 2004;5:495-502.
63. Mansell A, Smith R, Doyle SL et al. Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation. Nat Immunol 2006;7:148-55.
64. Saitoh T, Tun-Kyi A, Ryo A et al. Negative regulation of interferon-regulatory factor 3-dependent innate antiviral response by the prolyl isomerase Pin1. Nat Immunol 2006;7:598-605.
65. Boone DL, Turer EE, Lee EG et al. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol 2004;5:1052-60.
66. Kayagaki N, Phung Q, Chan S et al. DUBA: a deubiquitinase that regulates type I interferon production. Science 2007;318: 1628-32.
67. Carty M, Goodbody R, Schroder M et al. The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling. Nat Immunol 2006;7:1074-81.
68. Divanovic S, Trompette A, Atabani SF et al. Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105. Nat Immunol 2005;6:571-8.
69. Janssens S, Burns K, Tschopp J, Beyaert R. Regulation of interleukin-1- and lipopolysaccharide-induced NF-kappaB activation by alternative splicing of MyD88. Curr Biol 2002;12:467-71.
70. Diehl GE, Yue HH, Hsieh K et al. TRAIL-R as a negative regulator of innate immune cell responses. Immunity 2004;21:877-89.
71. Gilchrist M, Thorsson V, Li B et al. Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4. Nature 2006;441:173-8.
72. Iwami KI, Matsuguchi T, Masuda A et al. Cutting edge: naturally occurring soluble form of mouse Toll-like receptor 4 inhibits lipopolysaccharide signaling. J Immunol 2000;165:6682-6.
73. An H, Hou J, Zhou J et al. Phosphatase SHP-1 promotes TLR- and RIG-I-activated production of type I interferon by inhibiting the kinase IRAK1. Nat Immunol 2008; 9:542-50.
74. An H, Zhao W, Hou J et al. SHP-2 phosphatase negatively regulates the TRIF adaptor protein-dependent type I interferon and proinflammatory cytokine production. Immunity 2006;25:919-28.